A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)-Reference-Cited by-同舟云学术

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Published:2016-02 Issue:1 Volume:16 Page:38-44
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Gómez Henry L.,Neciosup Silvia,Tosello Célia^ORCID,Mano Max,Bines José,Ismael Gustavo,Santi Patrícia X.,Pinczowski Hélio,Nerón Yeni,Fanelli Marcello,Fein Luis,Sampaio Carlos,Lerzo Guillermo,Capó Adolfo,Zarba Juan J.,Blajman César,Varela Mirta S.,Martínez-Mesa Jeovany^ORCID,Werutsky Gustavo^ORCID,Barrios Carlos H.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

3. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

4. 2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial;Smith;Lancet,2007

5. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831;Perez;J Clin Oncol,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids;2023-12-20

2. Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine;European Journal of Breast Health;2023-04-01

3. Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer;Cancers;2023-03-14

4. Longitudinal drug synergy assessment using convolutional neural network image-decoding of glioblastoma single-spheroid cultures;Neuro-Oncology Advances;2023-01-01

5. Optimizing the future: how mathematical models inform treatment schedules for cancer;Trends in Cancer;2022-06